How brigatinib/brigatinib (Embry) accurately acts and kills cancer cells

Brigatinib/Brigatinib (Brigatinib) is a targeted drug. Its precise mechanism of action is mainly achieved by inhibiting ALK (anaplastic lymphoma kinase) gene mutations in cancer cells. Mutations or rearrangements of the ALK gene are a common causative factor in a variety of cancers, especially non-small cell lung cancer (NSCLC). Mutations in this gene keep the cell's growth signals on, causing cancer cells to grow and divide uncontrollably. Brigatinib achieves anti-cancer effects by precisely inhibiting the activity of ALK kinase and preventing the proliferation of cancer cells.

Brigatinib is a tyrosine kinase inhibitor (TKI), which can specifically bind to ALK kinase and inhibit its signal transduction function. The main function of ALK in cells is to promote cell proliferation by transmitting signals, especially in tumor cells. The mechanism of action of brigatinib is to inhibit the tyrosine kinase activity of ALK by binding to the ATP binding site of the ALK protein. In this way, ALK kinase cannot continue to promote cell proliferation and growth, eventually leading to apoptosis of cancer cells.

In addition, brigatinib also has the effect of overcoming certainALk mutation resistance. Traditional ALK inhibitors may lose their effectiveness over time due to drug resistance, but brigatinib shows strong inhibitory effects against certain ALk resistance mutations and can effectively overcome the resistance produced by the original drugs, thus providing a sustainable treatment option.

The role of brigatinib is not limited to inhibiting the proliferation of cancer cells, but can also effectively reduce damage to normal cells. Traditional chemotherapy drugs usually treat tumors by inhibiting cell division, but they often also affect normal cells, leading to greater side effects. As a targeted drug, brigatinib can directly act on specific gene mutations in tumor cells, reducing damage to normal cells, thereby alleviating side effects during treatment.

Reference materials:https://www.alunbrig.com/